International Journal of Clinical Pharmacology and Therapeutics · 2015 · 34 citations · 0 references
The consumption of the five classes of antihypertensive drugs in China nearly doubled from 2007 to 2012. The top-prescribed antihypertensive drug classes were CCBs and ARBs, and the latter increased most rapidly.